Rhodes. et al. shine a light on the criminalised coca trade through the lens of ‘ecological harm reduction’, inviting reflection on practices of care for humans, other living things, and environments, in contexts of structural violence.
UNODC outlines practical responses that government can take to address gender-based violence and HIV experienced by women and people of diverse gender identity and expression who use drugs.
IDPC summarises key wins and progress achieved between April 2022 and March 2023 toward ensuring that social justice and human rights are core tenets of drug policies.
IDPC draws on wide-ranging data from UN, government, academic and civil society sources to conclude that there has been little, incomplete or no progress in achieving the goals set out in the 2019 Ministerial Declaration on Drugs.
Nelson and Dumbili introduce a special issue of 'Drugs, Habits and Social Policy' that sheds light on the social and structural drivers of opioid use in the continent, and the impacts of restrictive policy.
The EMCDDA provide updated guidance to policy-makers and public health providers on developing strategies to prevent and control the spread of blood-borne infections among people who inject drugs.
The Lancet underscores the futility and harms of drug criminalisation, pointing to the growing evidence supporting decriminalisation and the expansion of harm reduction services.
The Robert Carr Fund's innovative grant-making model contributes to the empowerment of organizations engaged in HIV response through long-term funding, flexible core funding, and deliberate efforts towards shifting power to civil society.
